vimarsana.com
Home
Live Updates
Ultimovacs Receives Intention to Grant Notice on European Patent on UV1 Cancer Vaccine-Checkpoint Inhibitor Combinations : comparemela.com
Ultimovacs Receives Intention to Grant Notice on European Patent on UV1 Cancer Vaccine-Checkpoint Inhibitor Combinations
Protects UV1 vaccine-checkpoint inhibitor combinations in cancer until at least 2037Covers UV1 combined with CTLA-4, PD-1 or PD-L1 checkpoint inhibitorsNotice of intention to grant... | April 13, 2023
Related Keywords
Japan ,
Oslo ,
Norway ,
Canada ,
United States ,
Australia ,
Mary Ann Chang ,
European Patent Office ,
Trademark Office ,
European Patent ,
Patent Certificates ,
United States Patent ,
Carlos De Sousa ,
Chief Executive Officer ,
Ann Chang ,
Ultimovacs Asa Stock Exchange ,
News ,
Information ,
Press Release ,
Aprotects ,
Nv1 ,
Inhibitor ,
Combinations ,
N ,
Dancer ,
Until ,
It ,
Least ,
037covers ,
Combined ,
Ith ,
Dr ,
Checkpoint ,
Nhibitorsnotice ,
F ,
Intention ,
O Ulti No0010851603 ,
comparemela.com © 2020. All Rights Reserved.